Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Brain and Language
|
January 29, 2017
Unspeakable motion: Selective action-verb impairments in Parkinson's disease patients without mild cognitive impairment
Yamile Bocanegra, Adolfo M García, Francisco Lopera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Elkin Garcia-Cifuentes, Juan Camilo Becerra-Mateus, Claudia Aponte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Clinical Manifestations
Paula Ospina, Daniel Vasquez, Ana Y Baena, et al.
JAMA Network Open
|
December 2, 2020
Trajectory of Unawareness of Memory Decline in Individuals With Autosomal Dominant Alzheimer Disease
Patrizia Vannini, Bernard J Hanseeuw, Jennifer R Gatchel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 31, 2025
Association between basal forebrain volume and age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred
Bing He, Paula Ospina Lopera, Alejandro Espinosa, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 25, 2026
Web-based LAS-FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
Christopher Gonzalez Corona, Paula Ospina Lopera, Meredith C Rowe, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2026
Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred
Vincent Malotaux, Vivian Ku, Paula Ospina Lopera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 1, 2022
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial
Clara Vila-Castelar, Pierre N Tariot, Kaycee M Sink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 18, 2020
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial
Silvia Rios-Romenets, Francisco Lopera, Kaycee M Sink, et al.
The Lancet. Neurology
|
January 24, 2026
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
Pierre N Tariot, Francisco S Lopera, Silvia Ríos-Romenets, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Brain and Language
|
January 29, 2017
Unspeakable motion: Selective action-verb impairments in Parkinson's disease patients without mild cognitive impairment
Yamile Bocanegra, Adolfo M García, Francisco Lopera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Elkin Garcia-Cifuentes, Juan Camilo Becerra-Mateus, Claudia Aponte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Clinical Manifestations
Paula Ospina, Daniel Vasquez, Ana Y Baena, et al.
JAMA Network Open
|
December 2, 2020
Trajectory of Unawareness of Memory Decline in Individuals With Autosomal Dominant Alzheimer Disease
Patrizia Vannini, Bernard J Hanseeuw, Jennifer R Gatchel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 31, 2025
Association between basal forebrain volume and age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred
Bing He, Paula Ospina Lopera, Alejandro Espinosa, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 25, 2026
Web-based LAS-FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
Christopher Gonzalez Corona, Paula Ospina Lopera, Meredith C Rowe, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2026
Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred
Vincent Malotaux, Vivian Ku, Paula Ospina Lopera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 1, 2022
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial
Clara Vila-Castelar, Pierre N Tariot, Kaycee M Sink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 18, 2020
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial
Silvia Rios-Romenets, Francisco Lopera, Kaycee M Sink, et al.
The Lancet. Neurology
|
January 24, 2026
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
Pierre N Tariot, Francisco S Lopera, Silvia Ríos-Romenets, et al.
Page
of 1